Mayo Clinic researchers have identified a link between NFD and high-dose erythropoietin (EPO) administration in some patients. They continue to investigate other treatments and seek a cure for this condition.
See a list of publications by Mayo Clinic doctors on nephrogenic fibrosing dermopathy on PubMed, a service of the National Library of Medicine.
Research descriptions of individual investigators: